Executives On The Move: CEOs Welcomed At Cadent Therapeutics And Enzyvant Sciences, And Top Development Spot Filled At Bicycle Therapeutics
A new CEO for movement and cognitive disorder company Cadent Therapeutics, and Alexion SVP departs for CEO position at rare disease therapy firm Enzyvant Sciences. Plus transatlantic biotech Bicycle Therapeutics appoints a CBO, while Simon Moroney announces his departure from MorphoSys.
You may also be interested in...
The UK backs the world's first COVID-19 human challenge studies to accelerate research – though the first results will not be ready until mid-2021.
New chief business officer named at Ovoca Bio, and a new chairman at Opthea Ltd.
Plus Sanofi and Translate Bio release preclinical data from their COVID-19 vaccine candidate, another entrant to the now crowded mRNA vaccine field.